Search
Login
My Portfolios Login
TradeMachine® Login
CML Research Pro Login
Get TradeMachine®
Get CML Research
Compare Products
Home
My Portfolios
CMLViz News
Breaking
Stock
Scanner
Tear Sheet
News
Profile
Stats
Stock Chart
Pivot Points
Financial Charts
Holders
Analysts
Day Trader
Back-Tester
SPX
3,911.74
+124.00
(
+3.17%
)
Dow 30
+2.73%
QQQ
+3.56%
VIX
27.23
-1.82
(
-6.27%
)
Pfizer Inc.
NYSE:PFE
51.62
+1.53
(
+3.06%
)
4:02:09 PM EDT:
$51.46
-0.16 (-0.31%)
Products
Pfizer Granted FDA Fast Track Designation For Ervogastat/Clesacostat Combination For Treatment Of Non-Alcoholic Steatohepatitis
Published: 05/26/2022 11:05 GMT
PFE
Pfizer Inc. (
PFE
)
- Pfizer Granted FDA Fast Track Designation for Ervogastat/clesacostat Combination for the Treatment of Non-alcoholic Steatohepatitis (nash).